Your trusted source for investing success


Clayton Valley Lithium Exploration

Clayton Valley Lithium Exploration

Cypress Development has been exploring the eastern Clayton Valley throughout 2016, and discovered that lithium mineralization in the valley does not contain hectorite bearing claystones.

Newron Announces FDA Response to Re-Submitted NDA for Xadago®

Newron Pharmaceuticals, a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system and pain, and its partners announced today that the FDA considers the September 2016 re-submission of the NDA by Newron to be a complete, Class 2 response to FDA’s

Gold Outlook 2017!

Click here to get a clear perspective on the gold price and what the experts see coming in 2017 with our FREE Special Report (value of $49). Limited time offer. No credit card required.   Get My Free Report  
Enter Your Log In Credentials

Privacy & Legal Policy

Privacy Policy

Investing News Network